Computational design and discovery of nanomolar inhibitors of IκB kinase β.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of the American Chemical Society

• Publication date

  2015-01-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/ja510636tPMID 25513719
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure-based design, synthesis and biological evaluation of diphenylmethylamine derivatives as novel Akt1 inhibitors.

  2014cited by this paper
• Extended solvent-contact model approach to SAMPL4 blind prediction challenge for hydration free energies

  2014cited by this paper
• Crystal Structure of a Human IκB Kinase β Asymmetric Dimer

  2013cited by this paper
• Development of indole/indazole-aminopyrimidines as inhibitors of c-Jun N-terminal kinase (JNK): optimization for JNK potency and physicochemical properties.

  2013cited by this paper
• Development of amino-pyrimidine inhibitors of c-Jun N-terminal kinase (JNK): kinase profiling guided optimization of a 1,2,3-benzotriazole lead.

  2013cited by this paper
• Core refinement toward permeable β-secretase (BACE-1) inhibitors with low hERG activity.

  2013cited by this paper
• Design of potent and selective hybrid inhibitors of the mitotic kinase Nek2: structure-activity relationship, structural biology, and cellular activity.

  2012cited by this paper
• Models for Predicting IKKA and IKKB Blockade

  2012cited by this paper
• 4-Phenyl-7-azaindoles as potent, selective and bioavailable IKK2 inhibitors demonstrating good in vivo efficacy.

  2012cited by this paper
• Discovery of a novel IKK-β inhibitor by ligand-based virtual screening techniques

  2011cited by this paper
• Novel IκB kinase inhibitors for treatment of nuclear factor-κB-related diseases

  2011cited by this paper
• Crystal structure of inhibitor of κB kinase β (IKKβ)

  2011cited by this paper
• IKKbeta inhibitors identification part II: ligand and structure-based virtual screening.

  2010cited by this paper
• Synthesis and identification of new 4-arylidene curcumin analogues as potential anticancer agents targeting nuclear factor-κB signaling pathway.

  2010cited by this paper
• Synthesis and biological evaluation of tricyclic anilinopyrimidines as IKKbeta inhibitors.

  2010cited by this paper
• Expanding the Diversity of Allosteric Bcr-Abl Inhibitors

  2010cited by this paper
• IKK-beta inhibitors: an analysis of drug-receptor interaction by using molecular docking and pharmacophore 3D-QSAR approaches.

  2010cited by this paper
• Scoring functions and their evaluation methods for protein-ligand docking: recent advances and future directions.

  2010cited by this paper
• Discovery of 6-aryl-7-alkoxyisoquinoline inhibitors of IkappaB kinase-beta (IKK-beta).

  2009cited by this paper
• Protein-Ligand Docking Using Mutually Orthogonal Latin Squares (MOLSDOCK)

  2009cited by this paper
• Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability.

  2009cited by this paper
• Progress towards the development of anti-inflammatory inhibitors of IKKbeta.

  2009cited by this paper
• Inhibition of IkappaB kinase-beta and anticancer activities of novel chalcone adamantyl arotinoids.

  2008cited by this paper
• Synthesis and structure-activity relationship of aminopyrimidine IKK2 inhibitors.

  2008cited by this paper
• Integrating cell-signalling pathways with NF-κB and IKK function

  2007cited by this paper
• Integrating cell-signalling pathways with NF-kappaB and IKK function.

  2007cited by this paper
• A critical assessment of docking programs and scoring functions.

  2006cited by this paper
• Critical assessment of the automated AutoDock as a new docking tool for virtual screening

  2006cited by this paper
• Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK.

  2006cited by this paper
• A selective novel low‐molecular‐weight inhibitor of IκB kinase‐β (IKK‐β) prevents pulmonary inflammation and shows broad anti‐inflammatory activity

  2005cited by this paper
• Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs.

  2005cited by this paper
• A selective novel low-molecular-weight inhibitor of IkappaB kinase-beta (IKK-beta) prevents pulmonary inflammation and shows broad anti-inflammatory activity.

  2005cited by this paper
• Nuclear factor-κB inhibitors as sensitizers to anticancer drugs

  2005cited by this paper
• IκB kinases: key regulators of the NF-κB pathway

  2004cited by this paper
• The IKK NF-kappa B system: a treasure trove for drug development.

  2004cited by this paper
• Evaluation of docking performance: comparative data on docking algorithms.

  2004cited by this paper
• The IKK NF-κB system: a treasure trove for drug development

  2004cited by this paper
• Oncogenes and Tumor Suppressors (795 articles)

  2004cited by this paper
• IkappaB kinases: key regulators of the NF-kappaB pathway.

  2004cited by this paper
• Pharmaceutical profiling in drug discovery.

  2003cited by this paper
• AS602868, a pharmacological inhibitor of IKK2, reveals the apoptotic potential of TNF-α in Jurkat leukemic cells

  2003cited by this paper
• A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts.

  2003cited by this paper
• BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice.

  2003cited by this paper
• The design and synthesis of novel orally active inhibitors of AP-1 and NF-kappaB mediated transcriptional activation. SAR of in vitro and in vivo studies.

  2003cited by this paper
• BMS-345541 Is a Highly Selective Inhibitor of IκB Kinase That Binds at an Allosteric Site of the Enzyme and Blocks NF-κB-dependent Transcription in Mice*

  2003cited by this paper
• The design and synthesis of novel orally active inhibitors of AP-1 and NF-κB mediated transcriptional activation. SAR of In vitro and In vivo studies

  2003cited by this paper
• A Selective IKK-2 Inhibitor Blocks NF-κB-dependent Gene Expression in Interleukin-1β-stimulated Synovial Fibroblasts*

  2003cited by this paper
• Molecular Modeling of Fullerene Dendrimers

  2000cited by this paper
• LigBuilder: A Multi-Purpose Program for Structure-Based Drug Design

  2000cited by this paper
• Abnormal Morphogenesis But Intact IKK Activation in Mice Lacking the IKKα Subunit of IκB Kinase

  1999cited by this paper
• Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase.

  1999cited by this paper
• Ligand solvation in molecular docking

  1999cited by this paper
• SCORE: A New Empirical Method for Estimating the Binding Affinity of a Protein-Ligand Complex

  1998cited by this paper
• Recombinant IκB Kinases α and β Are Direct Kinases of IκBα*

  1998cited by this paper
• Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function

  1998cited by this paper
• Recombinant IkappaB kinases alpha and beta are direct kinases of Ikappa Balpha.

  1998cited by this paper
• An effective solvation term based on atomic occupancies for use in protein simulations

  1993cited by this paper
• Electrostatic effects in proteins: comparison of dielectric and charge models.

  1991cited by this paper

• Discovery and Structural Optimization of Novel 2-Aminopyrimidine Derivatives as Potent and Selective IKKβ Inhibitors for the Treatment of Colorectal Cancer.

  2025cites this paper
• Inhibitory Potential of the Drimane Sesquiterpenoids Isotadeonal and Polygodial in the NF-kB Pathway

  2025cites this paper
• Highly Stereoselective Synthesis of α-Substituted β-Hydroxy Sulfones via Ketoreductase-Catalyzed Dynamic Reductive Kinetic Resolution

  2025cites this paper
• The discovery of a novel IκB kinase β inhibitor based on pharmacophore modeling, virtual screening and biological evaluation.

  2024cites this paper
• Flavonoid diversity and roles in the lipopolysaccharide-mediated inflammatory response of monocytes and macrophages.

  2024cites this paper
• Polyethylene Glycol as a Green Medium for the Microwave‐Assisted Synthesis of Guanamines

  2023cites this paper
• A natural sesquiterpene lactone isolinderalactone attenuates lipopolysaccharide-induced inflammatory response and acute lung injury through inhibition of NF-κB pathway and activation Nrf2 pathway in macrophages.

  2023cites this paper
• Two-Track Virtual Screening Approach to Identify the Dual Inhibitors of Wild Type and C481S Mutant of Bruton's Tyrosine Kinase

  2022cites this paper
• Designing of kinase hinge binders: A medicinal chemistry perspective

  2022influential citation
• Multiple Target Drug Design Using LigBuilder 3.

  2021cites this paper
• Overexpression of DAPK1-mediated inhibition of IKKβ/CSN5/PD-L1 axis enhances natural killer cell killing ability and inhibits tumor immune evasion in gastric cancer.

  2021cites this paper
• Exploring the underlying mechanism of action of a traditional Chinese medicine formula, Youdujing ointment, for cervical cancer treatment

  2021cites this paper
• IKKβ mediates homeostatic function in inflammation via competitively phosphorylating AMPK and IκBα

  2021cites this paper
• Structure-based de novo drug design using 3D deep generative models

  2021cites this paper
• Kinase and GPCR polypharmacological approach for the identification of efficient anticancer medicines.

  2020cites this paper
• CPPF, A Novel Microtubule Targeting Anticancer Agent, Inhibits the Growth of a Wide Variety of Cancers

  2020cites this paper
• Design and synthesis of potent inhibitors of bc1 complex based on natural product neopeltolide.

  2020cites this paper
• Rational Computational Design of Fourth-Generation EGFR Inhibitors to Combat Drug-Resistant Non-Small Cell Lung Cancer

  2020cites this paper
• Thiazolidine-2,4-dione-based irreversible allosteric IKK-β kinase inhibitors: Optimization into in vivo active anti-inflammatory agents.

  2019cites this paper
• The compromise of virtual screening and its impact on drug discovery

  2019cites this paper
• Crosstalk between the Akt/mTORC1 and NF-κB signaling pathways promotes hypoxia-induced pulmonary hypertension by increasing DPP4 expression in PASMCs

  2019cites this paper
• Optimization study towards more potent thiazolidine-2,4-dione IKK-β modulator: Synthesis, biological evaluation and in silico docking simulation.

  2019cites this paper
• Identification of N-(5-(phenoxymethyl)-1,3,4-thiadiazol-2-yl)acetamide derivatives as novel protein tyrosine phosphatase epsilon inhibitors exhibiting anti-osteoclastic activity.

  2018cites this paper
• Target-based drug discovery through inversion of quantitative structure-drug-property relationships and molecular simulation: CA IX-sulphonamide complexes

  2018cites this paper
• Design, synthesis and biological evaluation of novel thiazolidinedione derivatives as irreversible allosteric IKK-β modulators.

  2018cites this paper
• N-Acetyl-3-aminopyrazoles block the non-canonical NF-kB cascade by selectively inhibiting NIK.

  2018cites this paper
• Discovery of EGF Receptor Inhibitors That Are Selective for the d746-750/T790M/C797S Mutant through Structure-Based de Novo Design.

  2017cites this paper
• Docking‐based In Silico Screening for Identification of Micromolar Inhibitors of Tropomyosin‐related Kinase A from Natural Origin

  2017cites this paper
• 4-Hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide: a novel inhibitor of the canonical NF-κB cascade.

  2017cites this paper
• Anticancer activity of a novel small molecule tubulin inhibitor STK899704

  2017cites this paper
• Divergent response of homologous ATP sites to stereospecific ligand fluorination for selectivity enhancement.

  2017cites this paper
• Discovery of Dual Inhibitors for Wild Type and D816V Mutant of c-KIT Kinase through Virtual and Biochemical Screening of Natural Products.

  2016cites this paper
• Discovery of Low Micromolar Dual Inhibitors for Wild Type and L1196M Mutant of Anaplastic Lymphoma Kinase through Structure-Based Virtual Screening

  2016cites this paper
• Optimization and biological evaluation of aminopyrimidine-based IκB kinase β inhibitors with potent anti-inflammatory effects.

  2016cites this paper
• Virtual Screening with Docking Simulations and Biochemical Evaluation of VHY Phosphatase Inhibitors.

  2015cites this paper
• Computational study on the inhibition mechanism of a cyclic peptide MaD5 to PfMATE: Insight from molecular dynamics simulation, free energy calculation and dynamical network analysis

  2015cites this paper
• Identification of β-Lapachone Analogs as Novel MALT1 Inhibitors To Treat an Aggressive Subtype of Diffuse Large B-Cell Lymphoma.

  2015cites this paper